Table 2 |
|||
|
Comorbidities of the participants |
|||
|
No erectile dysfunction (n = 23) |
Erectile dysfunction (n = 105) |
Odds ratio (95% confidence interval) |
|
|
|
|||
|
Cardiovascular risk factors |
|||
|
Systemic arterial hypertension |
14.3 |
24.1 |
1.11 (0.92 to 1.34) |
|
Diabetes mellitus |
4.4 |
6.9 |
1.08 (0.82 to 1.42) |
|
Coronary heart disease |
4.4 |
13.3 |
1.17 (0.98 to 1.39) |
|
Hypercholesterolaemia |
19.1 |
13.3 |
0.92 (0.70 to 1.21) |
|
History of smoking |
31.8 |
42.6 |
1.09 (0.92 to 1.29) |
|
Cigarette smoking (pack-years) |
15 (10 to 21) |
20 (9 to 30) |
P = 0.69 |
|
Medication |
|||
|
Antidepressant, sedative, neuroleptic or antiepileptic |
4.4 |
9.1 |
1.12 (0.89 to 1.40) |
|
Thiazides or spironolactone |
4.4 |
7.0 |
1.08 (0.82 to 1.43) |
|
Alcohol consumption (> 2 units/day) |
0 |
13.7 |
1.27 (1.15 to 1.40)* |
|
Other |
|||
|
Depression |
4.6 |
9.0 |
1.11 (0.88 to 1.39) |
|
Central nervous system problems |
0 |
3.9 |
1.23 (1.13 to 1.35)* |
|
Prostatic disease |
0 |
8.4 |
1.24 (1.13 to 1.36)* |
|
Hormonal (hypogonadism, hyperprolactinaemia) |
0 |
2.8 |
1.23 (1.11 to 1.36) |
|
Number of comorbidities per patient |
|||
|
At least one comorbidity |
52.2 |
61.5 |
1.07 (0.90 to 1.28) |
|
At least two comorbidities |
13.0 |
36.5 |
1.21 (1.05 to 1.40)* |
|
At least three comorbidities |
4.4 |
14.4 |
1.17 (1.00 to 1.34)* |
|
At least four comorbidities |
0 |
5.8 |
1.23 (1.13 to 1.35)* |
|
At least five comorbidities |
0 |
1 |
1.22 (1.13 to 1.33)* |
|
|
|||
|
Data presented as median (interquartile range) or percentage. The star (*) denotes statistical significance. |
|||
|
Foocharoen et al. Arthritis Research & Therapy 2012 14:R37 doi:10.1186/ar3748 |
|||